Who owns EFFECTOR THERAPEUTICS INC COM?
- CUSIP Number: 28202v108
Tip: Access positions for across all investors
Analyze quarterly positions in Effector Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Effector Therapeutics stock
Who bought or sold EFFECTOR THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Parallel Advisors | 68k | $975k | -96% | Mar 2024 |
|
| Blackstone Group | 52k | $753k | -96% | Mar 2024 |
|
Who sold out of Effector Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sr One Capital Management | Sep 2023 | 6.8M | $4.0M |
| Carlyle | Dec 2023 | 4.8M | $2.2M |
| Vanguard Group | Dec 2023 | 574k | $269k |
| Alyeska Investment Group | Dec 2023 | 365k | $4.3M |
| Geode Capital Management | Sep 2023 | 264k | $158k |
| Sonora Investment Management Group | Sep 2023 | 125k | $75k |
| Oasis Management | Sep 2023 | 100k | $60k |
| Two Sigma Securities | Dec 2023 | 62k | $29k |